Kirk E. Hevener - Concepedia

Author

Kirk E. Hevener

University of Tennessee Health Science Center ORCID

Also Known As

K. Hevener, K.E. Hevener, Kirk E Hevener, Kirk E. Hevener, Kirk E. Hevener (468717), Kirk Hevener, KirkE. Hevener

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center University of Illinois Chicago St. Jude Children's Research Hospital Texas A&M Health Science Center University of Hawaii at Hilo

About

Kirk E. Hevener is an author at University of Tennessee Health Science Center specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	968
2	Natural Sciences	6	6	816
3	Engineering	2	2	61
4	Education	1	1	38
5	Health Sciences	1	1	21

Kirk E. Hevener

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase Kirk E. Hevener, Wei Zhao, David M. Ball, Journal of Chemical Information and Modeling Drug TargetBioorganic ChemistryMolecular BiologyChemical BiologyPharmaceutical Chemistry	2009	597
Comparison of radii sets, entropy, <scp>QM</scp> methods, and sampling on <scp>MM‐PBSA</scp>, <scp>MM‐GBSA</scp>, and <scp>QM/MM‐GBSA</scp> ligand binding energies of <scp><i>F</i></scp><i>. tularensis</i> enoyl‐<scp>ACP</scp> reductase (<scp>F</scp>abI) Pin‐Chih Su, Cheng‐Chieh Tsai, Shahila Mehboob, Journal of Computational Chemistry	2015	125
A statistical framework to evaluate virtual screening Wei Zhao, Kirk E. Hevener, Stephen W. White, BMC Bioinformatics	2009	106
Structural Studies of Pterin-Based Inhibitors of Dihydropteroate Synthase Kirk E. Hevener, Mi-Kyung Yun, Jianjun Qi, Journal of Medicinal Chemistry	2009	91
Synthesis and Evaluation of Nitrofuranylamides as Novel Antituberculosis Agents Rajendra Tangallapally, Raghunandan Yendapally, Robin E. Lee, Journal of Medicinal Chemistry Medicinal ChemistryPulmonary TuberculosisBioorganic ChemistryMedicineTuberculosis Complex	2004	89
Discovery of a Novel and Potent Class of F. tularensis Enoyl-Reductase (FabI) Inhibitors by Molecular Shape and Electrostatic Matching Kirk E. Hevener, Shahila Mehboob, Pin-Chih Su, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryF. Tularensis Enoyl-reductaseBiomolecular Structure PredictionMolecular Biology	2011	67
Structure–activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors Kristopher G. Virga, Yong-Mei Zhang, Roberta Leonardi, Bioorganic & Medicinal Chemistry BiochemistryMedicineDrug DiscoveryMechanism Of ActionStructure–activity Relationships	2005	67
Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates Wan‐Jou Shen, Aditi Deshpande, Kirk E. Hevener, Journal of Antimicrobial Chemotherapy	2019	65
The Structure of the Pantothenate Kinase·ADP·Pantothenate Ternary Complex Reveals the Relationship between the Binding Sites for Substrate, Allosteric Regulator, and Antimetabolites Robert A. Ivey, Yong-Mei Zhang, Kristopher G. Virga, Journal of Biological Chemistry	2004	56
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile Abiola Olumuyiwa Olaitan, Chetna Dureja, Madison A. Youngblom, Nature Communications	2023	53

Page 1